Similar articles

• Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.

  Atzori L, Pinna AL, Ferreli C, Aste N. Atzori L, et al. Dermatol Online J. 2006 Jan 27;12(1):1. Dermatol Online J. 2006. PMID: 16638369 Review.
• Case reports: lisinopril-induced erythroderma in an 85-year-old male.

  Broski SE, Regan TD, Sturgill WH. Broski SE, et al. J Drugs Dermatol. 2008 Feb;7(2):163-6. J Drugs Dermatol. 2008. PMID: 18335653
• [Lisinopril-induced erythroderma].

  Schmutz JL, Barbaud A, Tréchot P. Schmutz JL, et al. Ann Dermatol Venereol. 2009 May;136(5):486. doi: 10.1016/j.annder.2009.02.001. Epub 2009 Apr 3. Ann Dermatol Venereol. 2009. PMID: 19442815 French. No abstract available.
• Pityriasis rosea-like adverse reaction to atenolol.

  Güleç Aİ, Albayrak H, Kayapinar O, Albayrak S. Güleç Aİ, et al. Hum Exp Toxicol. 2016 Mar;35(3):229-31. doi: 10.1177/0960327115580220. Epub 2015 Mar 18. Hum Exp Toxicol. 2016. PMID: 25791321
• Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.

  Drago F, Ciccarese G, Javor S, Parodi A. Drago F, et al. J Eur Acad Dermatol Venereol. 2016 Mar;30(3):544-5. doi: 10.1111/jdv.12942. Epub 2014 Dec 29. J Eur Acad Dermatol Venereol. 2016. PMID: 25545307 Review. No abstract available.